Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Management of Iron Supplements in Patients with Elevated Red Blood Cell Counts

Rationale for Discontinuing Iron Supplements

  • The European Society for Parenteral and Enteral Nutrition (ESPEN) recommends reducing iron stores through venesection in conditions of iron overload to prevent complications 1
  • Iron supplementation should be discontinued in patients with elevated red blood cell counts as this may indicate iron overload, which can lead to significant morbidity and mortality through organ damage 1

Assessment of Iron Status

  • Before making decisions about iron supplementation, a comprehensive iron status evaluation should include serum ferritin as the primary marker of iron stores 2
  • A complete blood count with RBC indices is necessary for assessing iron status 3
  • High RBC count with elevated ferritin (>1000 ng/mL) strongly suggests iron overload requiring intervention 2

Management Algorithm

  • For confirmed iron overload with high RBC, immediately discontinue all iron supplements and consider therapeutic phlebotomy if ferritin >1000 ng/mL 5, 6
  • Avoid vitamin C supplements which can increase iron absorption and mobilization in patients with iron overload 6

Monitoring After Discontinuation

  • Monitor hemoglobin and hematocrit regularly after stopping iron supplements, and check serum ferritin levels every 3 months until stabilized 2, 7
  • Target ferritin level should be between 50-100 μg/L to prevent both iron overload and deficiency 6

Risks of Continued Iron Supplementation with High RBC

  • Continued iron supplementation with elevated RBC can lead to cardiac dysrhythmias and cardiomyopathy 8
  • Liver damage and potential cirrhosis can occur with continued iron supplementation in patients with high RBC 5
  • Increased risk of infections, particularly from certain bacteria, is associated with iron overload 6
  • Hyperviscosity syndrome with headaches and poor concentration can result from continued iron supplementation with high RBC 3

Special Considerations

  • Patients with hereditary hemochromatosis require more aggressive management with regular therapeutic phlebotomy 9

Resuming Iron Supplementation

  • Iron supplementation should only be resumed when RBC count has normalized and ferritin levels have decreased to <50 μg/L, with clinical evidence of iron deficiency present 3, 4, 7